Status:
COMPLETED
WARD-Home - Continuous Monitoring of Vital Parameters After Discharge
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Technical University of Denmark
University Hospital Bispebjerg and Frederiksberg
Conditions:
Vital Sign
Clinical Deterioration
Eligibility:
All Genders
18+ years
Brief Summary
The current pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of...
Detailed Description
The healthcare system is challenged by an aging patient population with chronic diseases, and acute admissions must be housed in hospitals with fewer beds and less staff resources. This increases the ...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years) Admitted with an acute medical disease and scheduled for discharge to their own homes within five days from inclusion.
Exclusion
- Allergy to plaster, plastic, or silicone.
- A pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
- If the patient was deemed not able to open the front door when visited by the investigator.
- Inability to give informed consent.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05223504
Start Date
August 1 2021
End Date
June 15 2022
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg and Frederiksberg hospital
København NV, Region H, Denmark, 2400